B5H7, a Morpholine Derivative of 23-Hydroxybetulinic Acid, Reverses Doxorubicin Resistance in HepG2/ADM. (2014). Journal of Cancer Research Updates, 3(1),  59-66. https://doi.org/10.6000/1929-2279.2014.03.01.6